Basics |
Company: |
TransCode Therapeutics, Inc. |
IPO Date: |
July 9, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$5.62M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.11 | 6.03%
|
Avg Daily Range (30 D): |
$0.65 | 9.67%
|
Avg Daily Range (90 D): |
$0.33 | 7.64%
|
Institutional Daily Volume |
Avg Daily Volume: |
.1M |
Avg Daily Volume (30 D): |
2.5M |
Avg Daily Volume (90 D): |
.88M |
Trade Size |
Avg Trade Size (Sh.): |
21 |
Avg Trade Size (Sh.) (30 D): |
101 |
Avg Trade Size (Sh.) (90 D): |
85 |
Institutional Trades |
Total Inst.Trades: |
16 |
Avg Inst. Trade: |
$.76M |
Avg Inst. Trade (30 D): |
$.58M |
Avg Inst. Trade (90 D): |
$.58M |
Avg Inst. Trade Volume: |
.02M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$.65M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
.01K |
|
|
|
|
News |
Jul 23, 2024 @ 5:26 PM
Why Transcode Therapeutics (RNAZ) Stock Is Down 60...
Source: Henry Khederian
|
Jun 10, 2024 @ 12:07 PM
Beat the Market Like Zacks: Goldman Sachs, Micron,...
Source: Abhinab Dasgupta
|
Jun 10, 2024 @ 11:00 AM
Nasdaq Determines That TransCode Therapeutics Has ...
Source: TransCode Therapeutics, Inc.
|
May 29, 2024 @ 1:15 PM
TransCode Therapeutics Reports Positive Data from ...
Source: TransCode Therapeutics, Inc.
|
May 12, 2024 @ 10:18 AM
Successful Penny Stocks Trader Tips, 3 To Use
Source: D. Marie
|
Financials |
|
TTM |
Q2 2024 |
Q1 2024 |
Basic EPS
|
$-98.23
|
$-.74
|
$-.65
|
Diluted EPS
|
$-98.23
|
$-.74
|
$-.65
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -17.91M
|
$ -5.19M
|
$ -3.33M
|
Operating Income / Loss
|
$ -17.79M
|
$ -5.11M
|
$ -3.29M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -.22M
|
$ -1.56M
|
$ 2.15M
|
PE Ratio
|
|
|
|
Splits |
Dec 04, 2024:
33:1
|
Jan 16, 2024:
40:1
|
May 23, 2023:
20:1
|
|